Form4.ai tracks every SEC insider trade in real time. See every QNRX insider filing with a free account — no card.
See every QNRX insider filing — free account, no card.
Free accountQuoin Pharmaceuticals Ltd. (QNRX) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $280K. Most recent filing: Oct. 26, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 1, 2026 SEC filing | Carter Denise P. Chief Operating Officer Same trade as Myers Michael | Bought | $99,991 | -6.6% 30D |
| Sep 1, 2026 SEC filing | Lawlor Sally Bridget Chief Financial Officer | Bought | $49,991 | -6.6% 30D |
| Sep 1, 2026 SEC filing | Culverwell Anthony James Director | Bought | $29,992 | -6.6% 30D |
Create a free account to see all 7 QNRX filings from the last 90 days. No card needed.
Create free accountWant QNRX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.